4//SEC Filing
Smith Karen L. 4
Accession 0001842952-25-000076
CIK 0001842952other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 5:27 PM ET
Size
5.5 KB
Accession
0001842952-25-000076
Insider Transaction Report
Form 4
Smith Karen L.
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-12+123,500→ 123,500 totalExercise: $0.65Exp: 2035-06-11→ Common Stock (123,500 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001639637
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 5:27 PM ET
- Size
- 5.5 KB